Biote Appoints Richard Barrera to Board of Directors

biote ( (BTMD) ) just unveiled an announcement.

On June 5, 2025, Biote Corp. appointed Richard R. Barrera to its Board of Directors, filling the vacancy left by Steven J. Heyer’s resignation. Barrera, an experienced finance professional and founder of Roystone Capital, is expected to bring valuable insights to Biote’s growth strategy, aligning with the company’s long-term value creation goals. His appointment is seen as a strategic move to strengthen Biote’s board with financial expertise, potentially enhancing its market positioning and stakeholder confidence.

The most recent analyst rating on (BTMD) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on biote stock, see the BTMD Stock Forecast page.

Spark’s Take on BTMD Stock

According to Spark, TipRanks’ AI Analyst, BTMD is a Neutral.

BTMD’s stock score reflects a balance of strong revenue growth and attractive valuation against financial stability concerns due to negative equity. The technical analysis is mixed, and while strategic initiatives show promise, they are not without risks. Positive corporate events and earnings call insights add to the overall sentiment, but financial restructuring is necessary for sustained confidence.

To see Spark’s full report on BTMD stock, click here.

More about biote

Biote Corp. is a leading solutions provider in preventive health care, specializing in personalized hormone optimization and therapeutic wellness. The company focuses on transforming healthy aging by training practitioners to identify and treat early indicators of aging conditions, an underserved global market.

Average Trading Volume: 215,837

Technical Sentiment Signal: Hold

Current Market Cap: $146.7M

See more insights into BTMD stock on TipRanks’ Stock Analysis page.